Spruce Biosciences Inc. (SPRB)

AI Score

Unlock

0.12

-0.00 (-2.44%)

At close: Apr 17, 2025, 3:59 PM

0.12

-2.31%

After-hours: Apr 17, 2025, 07:58 PM EDT

Spruce Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	60.05M	69.68M	81.15M	96.34M	98.8M	97.48M	73.93M	24.49M	21.65M	47.21M	23.34M	42.75M	58.36M	78.28M	148.63M	157.15M	72.16M	36.6M	-3.92M	3.92M	-4.11M
Short-Term Investments	n/a	n/a	n/a	n/a	9.23M	23.04M	44.66M	54.59M	68.75M	46.09M	68M	46.22M	33.96M	30.95M	n/a	n/a	n/a	n/a	7.85M	n/a	8.22M
Long-Term Investments	n/a	n/a	35K	35K	34K	34K	29K	129K	216K	5.8M	17.6M	32.46M	38.98M	29.77M	216K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	531K	547K	518K	547K	573K	502K	496K	511K	667K	890K	894K	653K	631K	673K	473K	693K	3.02M	490K	-3.92M	40K	-4.11M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	3.4M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	860K	1.53M	1.61M	1.97M	419K	206K	253K	1.21M	2.79M	390K	325K	396K	301K	347K	272K	276K	209K	569K	n/a	513K	n/a
Total Current Assets	63.57M	73.91M	85.86M	102.18M	111.14M	124.13M	137.24M	83.61M	93.19M	96.51M	95.1M	91.89M	93.92M	111.37M	151.59M	160.4M	73.6M	38.48M	3.92M	4.65M	4.11M
Property-Plant & Equipment	998K	1.06M	1.12M	1.18M	1.24M	1.3M	1.35M	1.4M	1.23M	1.31M	1.4M	1.48M	1.56M	1.64M	1.72M	1.79M	1.87M	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.53M	1.61M	1.67M	1.76M	1.85M	1.83M	1.88M	2.04M	2.11M	8.01M	19.89M	34.59M	41.16M	32.08M	2.4M	2.49M	4.88M	490K	-3.92M	40K	-4.11M
Total Assets	65.1M	75.52M	87.54M	103.95M	112.98M	125.96M	139.11M	85.65M	95.3M	104.52M	114.99M	126.49M	135.09M	143.45M	153.99M	162.88M	78.48M	38.97M	n/a	4.69M	n/a
Account Payables	1.8M	682K	1.89M	3.33M	3.15M	945K	3.45M	1.43M	2.18M	1.45M	1.11M	2.82M	2.13M	1.11M	2.57M	3.63M	4M	2.66M	n/a	1.88M	n/a
Deferred Revenue	697K	1.3M	2.91M	4.91M	7.8M	8.06M	9.21M	n/a	n/a	-380K	n/a	-360K	1.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.62M	1.62M	1.62M	1.62M	1.62M	1.62M	1.62M	1.62M	1.22M	811K	405K	n/a	n/a	n/a	n/a	2.55M	1.91M	1.26M	n/a	1.25M	n/a
Other Current Liabilities	2.22M	8.68M	10.13M	11.25M	8.94M	10.19M	7.49M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	167K	n/a	n/a	n/a	n/a
Total Current Liabilities	11.86M	14.29M	18.39M	24.46M	24.19M	22.73M	23M	12.45M	12M	10.1M	8.97M	8.87M	9.06M	6.98M	6.85M	9.76M	10.09M	6.33M	n/a	4.3M	n/a
Long-Term Debt	524K	923K	1.32M	1.72M	2.11M	2.51M	2.9M	3.29M	3.69M	4.08M	4.49M	4.88M	4.87M	4.86M	4.84M	1.92M	2.56M	3.2M	n/a	3.19M	n/a
Other Long-Term Liabilities	273K	262K	250K	236K	220K	202K	181K	161K	139K	117K	95K	73K	51K	29K	8K	118K	115.54M	87K	n/a	27.83M	n/a
Total Long-Term Liabilities	1.61M	2.06M	2.52M	2.97M	3.42M	6.67M	8.12M	4.71M	4.82M	5.29M	5.78M	6.24M	6.31M	6.36M	6.42M	3.69M	119.84M	3.29M	n/a	31.03M	n/a
Total Liabilities	13.46M	16.35M	20.91M	27.44M	27.6M	29.4M	31.12M	17.16M	16.82M	15.39M	14.74M	15.12M	15.37M	13.34M	13.27M	13.46M	129.93M	9.62M	n/a	35.33M	n/a
Total Debt	3.23M	3.69M	4.15M	4.61M	5.06M	5.28M	5.73M	6.32M	6.29M	6.37M	6.46M	6.17M	6.61M	6.67M	6.74M	6.13M	6.21M	4.46M	n/a	4.45M	n/a
Common Stock	4K	4K	4K	4K	4K	4K	4K	3K	3K	3K	3K	3K	3K	3K	2K	2K	1K	1K	n/a	1K	n/a
Retained Earnings	-226.71M	-218.04M	-208.86M	-197.23M	-187.28M	-174.93M	-162.1M	-149.31M	-138.17M	-126.77M	-114.89M	-103.13M	-93.95M	-82.5M	-70.73M	-60.84M	-52.5M	-42.92M	n/a	-31.3M	n/a
Comprehensive Income	n/a	n/a	0.00	-0.00	-3K	-55K	-188K	-558K	-873K	-845K	-693K	-184K	-16K	-29K	-0.00	-0.00	-27.81M	-71.46M	-30.64M	-0.00	-17.8M
Shareholders Equity	51.64M	59.17M	66.62M	76.51M	85.38M	96.56M	108M	68.49M	78.47M	89.12M	100.24M	111.37M	119.72M	130.11M	140.72M	149.43M	-51.44M	29.35M	-2.82M	-30.64M	2.07M
Total Investments	n/a	35K	35K	35K	9.23M	23.04M	44.66M	54.59M	68.75M	51.89M	85.61M	78.68M	72.93M	60.71M	216K	n/a	n/a	n/a	7.85M	n/a	8.22M